TP53 and colorectal carcinoma: Regarding the antitumor effect of pan-HDACis in CRC, in vitro studies have shown that treatment with vorinostat induced cell death of CRC cell lines (Table 3) regardless of the p53 mutational status and led to the downregulation of mutated p53 and upregulation of the wild-type (wt) p53.